PLx Pharma OverviewPLx Pharma Research & Development
Research & Development expenses for PLXP.
Quarterly R&D Expenses
$623000.00
↓ 59.86% YoY
As of Sep 30, 2022
Annual R&D Expenses (TTM)
$2.52M
↓ 46.56% YoY
Trailing 12 months ending Sep 30, 2022
PLx Pharma OverviewResearch & Development expenses for PLXP.
As of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022